Novo Resources Corp. (NVO.V) (NVO) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free NVO Stock Alerts C$2.38 -0.01 (-0.42%) (As of 12/31/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 9:38 AM | seekingalpha.comNovo Nordisk falls on reports of fire at construction siteMay 15 at 3:33 PM | seekingalpha.comNovo Nordisk owner to acquire major stake in Austrian life sciences firmMay 15 at 10:32 AM | msn.comNovo Nordisk owner to acquire major stake in Australian life sciences firmMay 14, 2024 | msn.comNovo Nordisk to test obesity drugs including Wegovy in alcohol useMay 4, 2024 | msn.comUS FTC Inquires into Novo Nordisk’s Parent Company CatalentMay 3, 2024 | finance.yahoo.comNovo Resources Slightly Higher After Sharing a March Quarterly UpdateMay 3, 2024 | finance.yahoo.comNovo Resources Corp. March Quarterly UpdateMay 2, 2024 | morningstar.comNovo Resources Corp NVOMay 2, 2024 | abcnews.go.comNovo Nordisk announces $6B investment in Ozempic, Wegovy amid shortagesMay 2, 2024 | msn.comNovo Nordisk sales up 26% driven by GLP-1s, misses 11% on WegovyMay 2, 2024 | msn.comNovo Nordisk (NVO) Q1 2024 Earnings Call TranscriptMay 2, 2024 | msn.comNovo Nordisk lifts guidance as Ozempic, Wegovy sales surge; but stock falls 3%May 1, 2024 | finance.yahoo.comFollow-Up Drilling to Commence at Nunyerry North and New Targets Defined Near KarrathaApril 24, 2024 | msn.comWhat Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo NordiskApril 24, 2024 | msn.comNovo Nordisk comes under Senate probe over pricing of weight loss drugsApril 22, 2024 | seekingalpha.comNovo Nordisk Remains The Better Buy After A Moderate PullbackApril 18, 2024 | msn.comGerman Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs PipelineApril 18, 2024 | yahoo.comGerman watchdog approves Novo's acquisition of Cardior PharmaceuticalsMarch 29, 2024 | juniorminingnetwork.comKORE Appoints New Chief Financial Officer and DirectorMarch 27, 2024 | msn.comBernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And WegovyMarch 25, 2024 | msn.comNovo Nordisk Boosts Cardiovascular Pipeline With $1.1 Bln Purchase of Cardior Pharmaceuticals -- UpdateMarch 21, 2024 | msn.comWegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart HealthMarch 16, 2024 | msn.comNovo Nordisk's weight loss drug Wegovy could soon be covered by MedicareMarch 11, 2024 | juniorminingnetwork.comLIBERO COPPER SECURES $2.86M FINANCINGMarch 9, 2024 | msn.comFDA Approves Novo Nordisk’s Wegovy for Heart Disease Risk Reduction A Game-Changer for Obesity TreatmentMarch 9, 2024 | msn.comNovo Nordisk says its weight loss drug Wegovy is going to ChinaMarch 8, 2024 | msn.comNovo Nordisk’s Wegovy Wins US Approval as Heart TreatmentMarch 8, 2024 | msn.comUPDATE 1-FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risksMarch 7, 2024 | msn.comNovo Nordisk Shares Surge After Early Trial Shows New Obesity Drug Could Outperform WegovyMarch 7, 2024 | msn.comNovo Nordisk expects Wegovy approval in China this year: reportMarch 7, 2024 | msn.comNovo Nordisk stock spikes 10% to record high to eclipse Tesla market capMarch 7, 2024 | msn.comNovo Nordisk to present early drug trial data, Wegovy supply updateMarch 7, 2024 | msn.comNovo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialFebruary 28, 2024 | seekingalpha.comNovo Nordisk, A Very Healthy Pharma StalwartFebruary 12, 2024 | msn.comNovo Nordisk's controlling shareholder plans to invest up to $7 bln a year by 2030 - FTFebruary 10, 2024 | news.yahoo.comNovo Nordisk settles two lawsuits over copycat versions of Ozempic and WegovyFebruary 6, 2024 | msn.comNovo Nordisk's parent to buy Catalent for $16.5 billion to boost Wegovy supplyFebruary 6, 2024 | bizjournals.comNovo Nordisk considers multibillion-dollar expansion in NC as Wegovy, Ozempic take offFebruary 5, 2024 | news.yahoo.comNovo Nordisk announces plans to buy Catalent, one of Bloomington's biggest employersJanuary 31, 2024 | msn.comOzempic and Wegovy maker Novo Nordisk now worth $500B amid soaring popularityJanuary 31, 2024 | msn.comNovo Nordisk profit surges as it boosts supplies of WegovyJanuary 31, 2024 | msn.comNovo Nordisk Stock Hits Record High as Wegovy Maker Sees Up To 26% Sales Growth This YearJanuary 31, 2024 | msn.comObesity Drug WeGovy to Drive Up Profits at Novo NordiskJanuary 31, 2024 | finance.yahoo.comEmerita Provides Initial Drill Results for the El Cura Deposit, Iberian Belt West Project, SpainJanuary 31, 2024 | msn.comNovo Nordisk stock hits all-time high as Wegovy boosts 2023 resultsJanuary 31, 2024 | bloomberg.comNovo Nordisk Sees Profit Surging Again Amid Wegovy RolloutJanuary 29, 2024 | msn.com2 Rising Biotechs That Could Become the Next Novo NordiskJanuary 28, 2024 | msn.comIf You Invested $5,000 in Novo Nordisk in 2019, This Is How Much You Would Have TodayJanuary 15, 2024 | msn.comNovo Nordisk resumes U.S. shipments of Wegovy 1.7 mg doseJanuary 13, 2024 | msn.comNovo Nordisk resumes shipments of Wegovy 1.7 mg dose in US Get Novo Resources Corp. (NVO.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. NVO Media Mentions By Week NVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼-0.140.42▲Average Basic Materials News Sentiment NVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼42▲NVO Articles Average Week Get Novo Resources Corp. (NVO.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TECK.A News MUX News FOM News MND News POM News AR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:NVO) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Resources Corp. (NVO.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
